Aesku Diagnostics

Aesku.Group is a privately held, revenue-generating diagnostics company specializing in autoimmune disease testing. It has grown from a startup to a recognized global supplier with products in over 90 countries, supported by its own R&D and the non-profit AESKU.KIPP Institute for research collaboration. The company's strategy integrates diagnostic assays, automated instrumentation (like the HELIOS system), and software, recently bolstered by a significant exclusive U.S. distribution agreement with Thermo Fisher Scientific. Its future growth is tied to expanding its automated Point-of-Care platform and deepening its reach in core autoimmune markets.

Integrated autoimmune diagnostics platform featuring Indirect Immunofluorescence Assay (IFA) kits, ELISA, Blot, and Point-of-Care tests, coupled with full laboratory automation systems (HELIOS, HELIA, HELMED) and laboratory management/analysis software (HERA, AESKU.SCAN). Developing an automated platform for Point-of-Care testing.

Aesku competes in the autoimmune diagnostics space against major players like Thermo Fisher Scientific (Phadia), Werfen, and EUROIMMUN, as well as other specialty diagnostic companies. Its differentiation lies in its focused expertise in IFA, its integrated automation and software solutions, and its holistic group structure linking diagnostics with research and therapy exploration.